SL
PFE icon

Salomon & Ludwin’s Pfizer PFE Stock Holding History

Salomon & Ludwin’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68K Sell
2,847
-1
-0% -$26 0.01% 395
2026
Q1 		$80.7K Sell
2,848
-5
-0.2% -$133 0.01% 308
2025
Q4 		$71.8K Sell
2,853
-549
-16% -$13.8K 0.01% 312
2025
Q3 		$93.1K Buy
3,402
+3,081
+960% +$76K 0.01% 236
2025
Q2 		$8.13K Sell
321
-752
-70% -$17.5K ﹤0.01% 508
2025
Q1 		$27.2K Sell
1,073
-54
-5% -$1.41K ﹤0.01% 320
2024
Q4 		$29.9K Sell
1,127
-848
-43% -$23K ﹤0.01% 304
2024
Q3 		$57.2K Buy
1,975
+92
+5% +$2.68K 0.01% 244
2024
Q2 		$52.7K Sell
1,883
-7,061
-79% -$194K 0.01% 252
2024
Q1 		$248K Sell
8,944
-1,157
-11% -$32.1K 0.02% 164
2023
Q4 		$335K Hold
10,101
– – 0.04% 135
2023
Q3 		$335K Sell
10,101
-3
-0% -$106 0.04% 135
2023
Q2 		$371K Sell
10,104
-155
-2% -$6.03K 0.04% 133
2023
Q1 		$419K Sell
10,259
-369
-3% -$15.9K 0.05% 120
2022
Q4 		$545K Sell
10,628
-300
-3% -$14.4K 0.07% 104
2022
Q3 		$478K Buy
10,928
+2,235
+26% +$109K 0.07% 95
2022
Q2 		$456K Buy
8,693
+1,646
+23% +$83.9K 0.07% 81
2022
Q1 		$365K Buy
7,047
+1,192
+20% +$61.8K 0.05% 81
2021
Q4 		$346K Buy
+5,855
New +$290K 0.05% 77
2020
Q2 		– Sell
-941
Closed -$29K – 177
2020
Q1 		$29K Sell
941
-1,765
-65% -$60.1K 0.01% 116
2019
Q4 		$101K Buy
2,706
+1,765
+188% +$62.9K 0.02% 78
2019
Q3 		$32K Buy
941
+738
+364% +$26.8K 0.01% 118
2019
Q2 		$8K Sell
203
-121
-37% -$4.8K ﹤0.01% 174
2019
Q1 		$13K Buy
324
+121
+60% +$4.85K ﹤0.01% 150
2018
Q4 		$8K Buy
+203
New +$8.43K ﹤0.01% 165

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Salomon & Ludwin's PFE Position: Q2 2026 in Review

Salomon & Ludwin reduced its Pfizer (PFE) stake by 0.04% in Q2 2026, selling an estimated $26 and leaving 2,847 shares worth $68K. The position accounts for 0.01% of the portfolio, ranked #395.

Salomon & Ludwin first reported a position in PFE in Q4 2018 and has held it in 25 quarters since. The position peaked at $545K in Q4 2022. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Salomon & Ludwin held 2,847 shares of Pfizer worth $68K as of Q2 2026.
  • Salomon & Ludwin sold 1 Pfizer share in Q2 2026, an estimated $26.
  • Pfizer made up 0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #395 holding.
  • Salomon & Ludwin first reported a position in Pfizer in Q4 2018 and has held it in 25 quarters since.
  • Salomon & Ludwin's Pfizer position peaked at $545K in Q4 2022.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.